Heather Cohen

Heather Cohen currently serves as the Vice President of Precision Medicine & Biomarkers at Myeloid Therapeutics since December 2024. Prior to this role, Heather held various positions at Bicycle Therapeutics from August 2020 to October 2024, including Senior Director and Director in Translational Sciences. From October 2015 to August 2020, Heather worked at Jounce Therapeutics, Inc. as a Principal Scientist in Translational Biology and progressed through roles as Senior Scientist and Scientist in Discovery Biology. Earlier experience includes a Postdoctoral Fellowship at EMD Serono, Inc. focusing on Biomarker Sciences, and a tenure at the University of Maryland as a Postdoctoral Fellow and Ph.D. candidate in Immunology, where extensive research on macrophage regulation was conducted. Heather began academic pursuits at the University of Minnesota, obtaining a Bachelor of Science in Genetics, Cell, and Developmental Biology in 2006.